Latest News

Treasury Wine Estates (ASX:TWE) has just released its H1 2026 scorecard. Recent halves showed revenue of A$1.57 billion in H1 2025 and A$1.42 billion in H2 2025, alongside basic EPS of A$0.27 and A$0.27 respectively. This compares with the prior H2 2024 period where revenue was A$1.49 billion and basic EPS was a loss of A$0.08 per share. The company’s trailing twelve month revenue has been between A$2.73 billion and A$3.07 billion across recent periods, with basic EPS ranging from A$0.19 to...

Kirin Holdings Company reported past full-year 2025 results with revenue of ¥2,433,363 million and net income of ¥147,542 million, alongside announcing higher cash dividends of ¥37.00 per share for the year ended December 31, 2025, with distribution commencing on March 30, 2026. The company paired this profit and dividend update with 2026 earnings guidance and further progress in its Immunosens self-testing health partnership, highlighting a broader push into healthcare-related...

If you are looking at Louisiana-Pacific and asking whether the current share price lines up with the underlying business, you are in the right place. The stock closed at US$93.62, with a 5.0% decline over the last 7 days, a 0.5% return over 30 days, a 14.5% return year to date, and returns of a 15.7% decline over 1 year, 50.3% over 3 years, and 110.4% over 5 years. These mixed returns hint that the market has been reassessing both the potential and the risks around Louisiana-Pacific. To...

Tess Holdings Co.,Ltd.'s ( TSE:5074 ) dividend will be increasing from last year's payment of the same period to ¥5.80...

Key Insights Bleach's estimated fair value is JP¥298 based on 2 Stage Free Cash Flow to Equity Bleach's JP¥264 share...

Sprinklr: recent performance snapshot Sprinklr (CXM) has been on the radar for its recent share performance, with the stock around $5.49 and returns showing pressure over the past month, the past 3 months, and over the past year. See our latest analysis for Sprinklr. With the share price at US$5.49, Sprinklr’s recent 1 day share price return of 1.86% comes after a softer patch. The 30 day share price return of 17.07% and 1 year total shareholder return of 38.86% may suggest fading momentum...

HomeCo Daily Needs REIT has reported its half-year results for the period to 31 December 2025, posting A$190.4 million in sales and A$243.5 million in net income, with basic and diluted earnings per share of A$0.1167. The sharp uplift in net income and earnings per share versus the prior year suggests meaningful operational progress within the daily needs-focused portfolio. Next, we’ll examine how this strong half-year uplift in net income could influence HomeCo Daily Needs REIT’s existing...

In February 2026, International Flavors & Fragrances Inc. reported mixed fourth-quarter 2025 results, with sales of US$2,589 million down from US$2,771 million a year earlier, a swing to full-year 2025 net loss of US$374 million, and issued 2026 sales guidance of US$10.50–US$10.80 billion alongside adjusted EBITDA guidance of US$2.05–US$2.15 billion. At the same time, IFF accelerated its portfolio reshaping by launching a formal sale process for its Food Ingredients business and outlining a...

Alamos Gold (TSX:AGI) is back in focus after its Island Gold District Expansion Study outlined a 30% increase in mineral reserves and a larger Magino mill processing rate of 3,000 tonnes per day. See our latest analysis for Alamos Gold. The Island Gold District news lands on top of a strong run, with a 30.3% 90 day share price return and a very large 5 year total shareholder return. This suggests momentum has been building as investors reassess growth potential and project execution risk. If...

BlueMeme Inc. ( TSE:4069 ) shareholders that were waiting for something to happen have been dealt a blow with a 30...

Why Zimmer Biomet stock is back in focus Zimmer Biomet Holdings (ZBH) is back on investors radar after fourth quarter and full year 2025 results topped revenue and profit expectations, supported by hip and knee demand and progress in robotic assisted surgical systems. See our latest analysis for Zimmer Biomet Holdings. The recent results and fresh US$1.5b buyback authorization have coincided with a 7.5% 7 day share price return and 10.5% 30 day share price return. However, the 1 year total...

The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better...

Charter Hall Long WALE REIT recently reported higher H1 FY26 operating earnings, a A$139 million portfolio valuation uplift, and completed A$455 million of acquisitions alongside A$79 million of divestments, while reaffirming its FY26 operating earnings and distribution guidance. A key highlight was the purchase of a 49.9% interest in Coles’ new automated distribution centre on a 20‑year lease, reinforcing the REIT’s focus on long-duration, high-quality income backed by corporate and...

Greens Co.,Ltd. ( TSE:6547 ) has announced that it will be increasing its dividend from last year's comparable payment...

Recent performance context for Braze Braze (BRZE) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. See our latest analysis for Braze. With the share price at $17.60, Braze’s recent momentum has been weak, with a 30 day share price return of 23.58% and a 1 year total shareholder return of 57.60%. This points to fading sentiment and higher perceived risk...

In February 2026, TC Energy reported fourth-quarter and full-year 2025 results showing higher quarterly sales of C$303 million and quarterly net income of C$1.02 billion, alongside a 3.2% increase in its quarterly common share dividend to C$0.8775 per share, payable on April 30, 2026. Beyond the headline earnings beat, TC Energy highlighted a 9% year-over-year rise in comparable EBITDA and placed C$8.30 billion of projects into service more than 15% under budget, extending its dividend...

Ocular Therapeutix reported fourth-quarter 2025 revenue of US$13.25 million and a net loss of US$64.65 million, and filed an US$8.29 million shelf registration for 974,000 common shares tied to its employee stock plans. The company also recently hosted a webcast to share topline Phase 3 SOL-1 data for its investigational AXPAXLI therapy in wet age-related macular degeneration, a program that could materially influence its long-term pipeline value and competitive positioning in retinal...

In early February 2026, Atmos Energy shareholders approved extensive amendments to the company’s charters and bylaws, including lifting authorized common shares to 400 million and updating rules on director elections, officer liability, indemnification, meeting procedures, and legal forums. These governance changes, together with the board’s alignment on modernized bylaws, give Atmos Energy greater flexibility for future capital raising and corporate actions while tightening legal and...

Sakai Chemical Industry Co., Ltd.'s ( TSE:4078 ) dividend will be increasing from last year's payment of the same...

Key Insights Institutions' substantial holdings in YASKAWA Electric implies that they have significant influence over...

IBM (NYSE:IBM) is under heavier scrutiny from investors and industry analysts over its artificial intelligence strategy. Prominent short sellers have publicly criticized IBM's positioning and execution in AI. At the same time, IBM is launching new AI driven products, including a next generation FlashSystem with agentic AI features. The company is also expanding hiring for entry level roles tied to AI focused work and next generation tech skills. For you as an investor, this mix of criticism...

Starbucks (SBUX) is back in focus after management highlighted stronger sales growth tied to its Back to Starbucks plan, with higher transaction volumes and average ticket size supporting rising global comparable store sales. See our latest analysis for Starbucks. Despite the Back to Starbucks plan gaining traction, the share price has been under some pressure recently, with a 1 day share price return of 3.07% decline and a 7 day share price return of 5.24% decline. The 90 day share price...

If you are wondering whether DRDGOLD's share price still reflects fair value after its recent run, this article walks through the key valuation checks to help you frame that question clearly. The stock last closed at US$35.65, with a 1.6% return over 7 days, a 1.6% decline over 30 days and returns of 17.6% year to date, 251.3% over 1 year, 412.2% over 3 years and 327.9% over 5 years. Recent coverage has focused on DRDGOLD's share price performance and how investors are reacting to changes in...

If you are wondering whether Duolingo is starting to look attractive or still priced for perfection, the recent share price moves give you a lot to think about. The stock closed at US$112.57, with returns of a 5.3% decline over 7 days, a 25.0% decline over 30 days, a 36.2% decline year to date, and a 74.0% decline over the past year, even though the 3 year return sits at 23.2%. Recent coverage has focused on how Duolingo fits into the broader shift toward app based learning and subscription...